CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $1.59M invested in Can-Fite BioPharma in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$35.7K
2
+$12.9K

Top Sellers

1
-$20K
2
-$14.6K
3
-$2K
4
PCM
Prelude Capital Management
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.19M
2
$240K
3
$97K
4
$29K
5
$18K
6
$12K
7
$5K
8
$4K
9
$1K
10
–
11
–